Thema
Journal Article
41
Research Support, Non-U.S. Gov't
22
Antibodies, Viral
19
Influenza Vaccines
15
Vaccines, DNA
14
Hemagglutinin Glycoproteins, Influenza Virus
10
DNA vaccine
9
615
8
COVID-19 Vaccines
8
che
8
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
7
Histocompatibility Antigens Class II
7
Influenza
6
APC-targeting
5
COVID-19
5
Hemagglutinins
5
influenza
5
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
4
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
4
Observational Study
4
Receptors, Chemokine
4
SARS-CoV-2
4
Spike Glycoprotein, Coronavirus
4
Vaccine
4
Vaccines
4
Viral Vaccines
4
spike protein, SARS-CoV-2
4
vaccine
4
Antibodies, Neutralizing
3
Antigens
3
Inflammatory bowel disease
3
Rheumatic diseases
3
SARS-CoV-2 vaccine
3
Serologic response
3
T cells
3
influenza vaccines
3
570
2
APC targeting
2
APC-targeted antigen
2
Antigen presenting cells
2
Antigens, Viral
2
Biology
2
Chemokine CCL3
2
Cytotoxic
2
DNA vaccines
2
Dendritic cells
2
HLA Antigens
2
Immunoglobulin G
2
Interferon-alpha
2
Nucleoprotein
2
mehr ...